A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.
Anna R DamatoRuth G N KatumbaJingqin R LuoHimachandana AtluriGrayson R TalcottAshwin GovindanEmily A SlatKatherine N WeilbaecherYu TaoJiayi HuangOmar H ButtGeorge AnsstasTanner M JohannsMilan G ChhedaErik D HerzogJoshua B RubinJian L CampianPublished in: Neuro-oncology practice (2022)
Chronotherapy with TMZ is feasible. A larger study is needed to validate the effect of chronotherapy on clinical efficacy.
Keyphrases